C
Cellular Dynamics International
Develops and manufactures biologically relevant human cells derived from induced pluripotent stem (iPS) cells
About Cellular Dynamics International
Fujifilm Cellular Dynamics, a subsidiary of Fujifilm, specializes in the development and manufacturing of induced pluripotent stem cells (iPSCs) for various applications including drug discovery, safety pharmacology, and regenerative medicine. The company serves pharmaceutical companies, research institutions, and biotech firms by providing high-quality iPSC-derived cells such as cardiomyocytes, neurons, and other specialized cell types. Operating in the biotechnology and life sciences market, Fujifilm Cellular Dynamics leverages its proprietary episomal reprogramming technology to produce iPSCs at an industrial scale. The business model revolves around the sale of iCell products, custom cell development services, and collaborative research agreements. Revenue is generated through product sales, service contracts, and strategic partnerships aimed at advancing therapeutic approaches and drug discovery solutions.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2004
- Headquarters
- Madison, United States
- Employees
- 194
- Open positions
- None listed
- Dealroom signal
- 42.8/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Cardiology and cardiovascular, Spinout, Biotech and Pharma, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
- Investment activity
- 1 company, latest Jul 2019
- Capital deployed
- $250M
- Preferred round
- SERIES A
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Mar 2015 | $307M | $307M | FUJIFILM | — |
| IPOOther financing | Jul 2013 | $46M | $204M | Undisclosed | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Cellular Dynamics International is 250 monthly website visits, up 4.2% over the last three months. Cellular Dynamics International's team grew 26.8% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
WARF Ventures- TVTactics II Stem Cell Ventures
EGI Group
Series B and later1 investor entered at this stage
Rose Tech Ventures
Other known investors2 additional known investors
FUJIFILM
University of Wisconsin-Madison
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Cellular Dynamics International on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cellular Dynamics International’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.